REN and hypertensive disorder: Systemic arterial hypertension (HTN) was found to be an independent risk factor for CVD development, and its treatment has been proven to reduce CVD-related mortality.[1] The renin-angiotensin-aldosterone system (RAAS), which plays a primary role in the pathogenesis of essential HTN,[2] is activated in volume-depleted states.